Warfarin-induced skin necrosis in HIV-1-infected patients with tuberculosis and venous thrombosis

South African Medical Journal

Volumn 100, Issue 6, 2010, Pages 372-377

  Bhaijee, F ^a,b   Wainwright, H ^a,b   Meintjes, G ^b,c   Wilkinson, R J ^a,b,c,d,e   Todd, G ^a   de Vries, E ^b   Pepper, D J ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c GF Jooste Hospital   (South Africa)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; EFAVIRENZ; ERTAPENEM; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; HEPARIN; IMIPENEM; LAMIVUDINE; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; STAVUDINE; TOBRAMYCIN; TUBERCULOSTATIC AGENT; VANCOMYCIN; WARFARIN; ZIDOVUDINE;

ACINETOBACTER; ADULT; BEDTIME DOSAGE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER FLOWMETRY; DRUG MEGADOSE; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERCOAGULABILITY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTERNATIONAL NORMALIZED RATIO; KLEBSIELLA PNEUMONIAE; LOADING DRUG DOSE; LUNG TUBERCULOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PATIENT REFERRAL; RETROSPECTIVE STUDY; REVIEW; SKIN BIOPSY; SKIN GRAFT; SKIN NECROSIS; SOUTH AFRICA; SURVIVAL; VEIN THROMBOSIS; WARFARIN INDUCED SKIN NECROSIS;

EID: 77954068163     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.3565     Document Type: Review

References (23)

1. Warkentin TE, Sikov WM, Lillicrap DP. Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopenia. Am J Hematol 1999; 62(1): 44-48.
2. Irwin RS, Rippe JM. Warfarin induced skin necrosis. In: Irwin and Rippe's Intensive Care Medicine. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2007: 2267.
3. Verhagen H. Local haemorrhage and necrosis of the skin and underlying tissues, during anticoagulant therapy with dicumarol or dicumacyl. Acta Med Scand 1954; 148(6): 453-467.
4. Chan YC, Valenti D, Mansfield AO, Stansby G. Warfarin induced skin necrosis. Br J Surg 2000; 87(3): 266-272.
5. Pepper DJ, Maartens G, Rebe K, et al. Neurological manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infect Dis 2009; 48(11): e96-107.
6. Pepper DJ, Rebe K, Morroni C, Wilkinson RJ, Meintjes G. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses. PLoS ONE 2009; 4(2): e4520.
7. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008; 8(8): 516-523.
8. Cole MS, Minifee PK, Wolma FJ. Coumarin necrosis - a review of the literature. Surgery 1988; 103(3): 271-277.
9. Broekmans AW, Bertina RM, Loeliger EA, Hofmann V, Klingemann HG. Protein C and the development of skin necrosis during anticoagulant therapy. Thromb Haemost 1983; 49(3): 251.
10. Comp PC, Elrod JP, Karzenski S. Warfarin-induced skin necrosis. Semin Thromb Hemost 1990; 16(4): 293-298.
11. Essex DW, Wynn SS, Jin DK. Late-onset warfarin-induced skin necrosis: case report and review of the literature. Am J Hematol 1998; 57(3): 233-237.
12. Marais E, Aithma N, Perovic O, et al. Antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus isolates from South Africa. S Afr Med J 2009; 99: 170-173.
13. McKnight JT, Maxwell AJ, Anderson RL. Warfarin necrosis. Archives of Family Medicine 1992; 1: 105-108.
14. Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivisto KT. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003; 42(9): 819-50.
15. Saber AA, Aboolian A, LaRaja RD, Baron H, Hanna K. HIV/AIDS and the risk of deep vein thrombosis: a study of 45 patients with lower extremity involvement. Am Surg 2001; 67(7): 645-647.
16. Ahonkhai AA, Gebo KA, Streiff MB, Moore RD, Segal JB. Venous thromboembolism in patients with HIV/AIDS: a case-control study. J Acquir Immune Defic Syndr 2008; 48(3): 310-304.
17. Crum-Cianflone NF, Weekes J, Bavaro M. Review: thromboses among HIV-infected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDS 2008; 22(10): 771-778.
18. Saif MW, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 2001; 15(6): 311-320.
19. Lijfering WM, Sprenger HG, Georg RR, van der Meulen PA, van der Meer J. Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection. Clin Chem 2008l; 54(7): 1226-1233.
20. Saif MW, Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS 2001; 15(1): 15-24.
21. White NW. Venous thrombosis and rifampicin. Lancet 1989; 334: 434-435.
22. Turken O, Kunter E, Sezer M, et al. Hemostatic changes in active pulmonary tuberculosis. Int J Tuberc Lung Dis 2002; 6(10): 927-932.
23. Tahir M, Sinha S, Sharma SK, Mitsuyasu RT. Immune reconstitution inflammatory syndrome manifesting as disseminated tuberculosis, deep venous thrombosis, encephalopathy and myelopathy. Indian J Chest Dis Allied Sci 2008; 50(4): 363-364.